Journal ArticleOPEN ACCESS

Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer

Obstetrics and Gynecology Science (2020) 63(6) 709-718
DOI: 10.5468/OGS.20117
19Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The need for tailoring ovarian cancer treatments to individual patients is increasing. This study aimed to evaluate the prognostic value of pretreatment laboratory test data for predicting the response and survival outcomes of platinumbased chemotherapy in ovarian cancer.

Author supplied keywords

Cite

CITATION STYLE

APA

Ikeda, A., Yamaguchi, K., Yamakage, H., Abiko, K., Satoh-Asahara, N., Takakura, K., & Konishi, I. (2020). Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer. Obstetrics and Gynecology Science, 63(6), 709–718. https://doi.org/10.5468/OGS.20117

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free